OP-ED: PROTECT PATENT RIGHTS
Don’t Sacrifice American Innovation on the Altar of “March-In” By Niels Reimers NIELS REIMERS A DC-based advocacy group has just petitioned the government to seize the patent covering the prostate cancer drug Xtandi so generic manufacturers can copy the medication. The group behind this petition has issued similar calls in the past. But both […]
